| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Konstantin Severinov | |
| Dmitrii Y Travin | |||
| Dmitry Bikmetov | |||
| P2860 | cites work | antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline | Q91588102 |
| Bioinformatic Mapping of Radical S-Adenosylmethionine-Dependent Ribosomally Synthesized and Post-Translationally Modified Peptides Identifies New Cα, Cβ, and Cγ-Linked Thioether-Containing Peptides | Q91787133 | ||
| Thiazoline-Specific Amidohydrolase PurAH Is the Gatekeeper of Bottromycin Biosynthesis | Q92706717 | ||
| Natural product drug discovery in the genomic era: realities, conjectures, misconceptions, and opportunities | Q93359785 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| The HHpred interactive server for protein homology detection and structure prediction | Q24530456 | ||
| Thiopeptide antibiotics: retrospective and recent advances | Q26852567 | ||
| The crystal structure of Cys-tRNACys-EF-Tu-GDPNP reveals general and specific features in the ternary complex and in tRNA | Q27618632 | ||
| Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu | Q27620929 | ||
| Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin | Q27650303 | ||
| Structural Basis for Microcin C7 Inactivation by the MccE Acetyltransferase | Q27667486 | ||
| Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor | Q27667906 | ||
| Structure and function of a serine carboxypeptidase adapted for degradation of the protein synthesis antibiotic microcin C7 | Q27677830 | ||
| Structural and functional insight into an unexpectedly selective N-methyltransferase involved in plantazolicin biosynthesis | Q27679181 | ||
| Structure and Substrate Recognition of the Bottromycin Maturation Enzyme BotP | Q27728097 | ||
| Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? | Q28076750 | ||
| Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization | Q28333398 | ||
| ThioFinder: a web-based tool for the identification of thiopeptide gene clusters in DNA sequences | Q28483962 | ||
| Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation | Q28603064 | ||
| Drug discovery and natural products: end of an era or an endless frontier? | Q30866998 | ||
| The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C | Q33299160 | ||
| Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes | Q33369065 | ||
| Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93. | Q33601961 | ||
| A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. | Q33987554 | ||
| Escherichia coli RNA polymerase is the target of the cyclopeptide antibiotic microcin J25. | Q33996646 | ||
| Clostridiolysin S, a post-translationally modified biotoxin from Clostridium botulinum | Q34107450 | ||
| Selectivity, directionality, and promiscuity in peptide processing from a Bacillus sp. Al Hakam cyclodehydratase | Q34188549 | ||
| YcaO domains use ATP to activate amide backbones during peptide cyclodehydrations | Q34269958 | ||
| Synthetic biotechnology to study and engineer ribosomal bottromycin biosynthesis | Q34302589 | ||
| Mode of action of bottromycin A2. Release of aminoacyl- or peptidyl-tRNA from ribosomes | Q34307700 | ||
| Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature | Q34312732 | ||
| Maturation of an Escherichia coli ribosomal peptide antibiotic by ATP-consuming N-P bond formation in microcin C7. | Q46741185 | ||
| Proposed systematic nomenclature for orbitides | Q46757322 | ||
| Macroamidine Formation in Bottromycins Is Catalyzed by a Divergent YcaO Enzyme. | Q47329985 | ||
| In Vitro Biosynthetic Studies of Bottromycin Expand the Enzymatic Capabilities of the YcaO Superfamily | Q47336037 | ||
| The Product of Yersinia pseudotuberculosis mcc Operon Is a Peptide-Cytidine Antibiotic Activated Inside Producing Cells by the TldD/E Protease | Q47633927 | ||
| Thiostrepton binds to malarial plastid rRNA. | Q48036549 | ||
| Insights into the Biosynthesis of Dehydroalanines in Goadsporin. | Q48095228 | ||
| Cracking the Nonribosomal Code. | Q51324460 | ||
| Enzymatic reconstitution of ribosomal peptide backbone thioamidation. | Q52673245 | ||
| Biosynthesis of Translation Inhibitor Klebsazolicin Proceeds through Heterocyclization and N-Terminal Amidine Formation Catalyzed by a Single YcaO Enzyme. | Q52722891 | ||
| The molecular mechanism of aminopropylation of peptide-nucleotide antibiotic microcin C. | Q54285449 | ||
| From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase. | Q54577148 | ||
| The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics. | Q55007999 | ||
| Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria. | Q55404502 | ||
| Structural Basis of the Action of Pulvomycin and GE2270 A on Elongation Factor Tu†,‡ | Q57978158 | ||
| Roads to Rome: Role of Multiple Cassettes in Cyanobactin RiPP Biosynthesis | Q58616708 | ||
| Uncovering the unexplored diversity of thioamidated ribosomal peptides in Actinobacteria using the RiPPER genome mining tool | Q64114332 | ||
| Architecture of Microcin B17 Synthetase: An Octameric Protein Complex Converting a Ribosomally Synthesized Peptide into a DNA Gyrase Poison | Q64120548 | ||
| Biosynthesis of the RiPP trojan horse nucleotide antibiotic microcin C is directed by the N-formyl of the peptide precursor. | Q64946052 | ||
| Mode of action of bottromycin A2: effect on peptide bond formation | Q67300898 | ||
| Mode of action of bottromycin A2: Effect of bottromycin A2 on polysomes | Q70241262 | ||
| Inhibition of Protein Synthesis by Bottromycin A2 and Its Hydrazide | Q71209005 | ||
| Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic Microcin C | Q83017792 | ||
| Genome mining reveals a minimum gene set for the biosynthesis of 32-membered macrocyclic thiopeptides lactazoles | Q87757867 | ||
| Rapid and Robust Yeast-Mediated Pathway Refactoring Generates Multiple New Bottromycin-Related Metabolites | Q88470236 | ||
| Bioinformatic Expansion and Discovery of Thiopeptide Antibiotics | Q89460096 | ||
| Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition | Q90597981 | ||
| MIBiG 2.0: a repository for biosynthetic gene clusters of known function | Q90711572 | ||
| MMseqs2 desktop and local web server app for fast, interactive sequence searches | Q90919096 | ||
| A computational framework to explore large-scale biosynthetic diversity | Q91452561 | ||
| Biosynthesis and mode of action of lantibiotics. | Q34392391 | ||
| Thiopeptide antibiotics | Q34392398 | ||
| Identification of an Auxiliary Leader Peptide-Binding Protein Required for Azoline Formation in Ribosomal Natural Products. | Q34478499 | ||
| Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants | Q34520644 | ||
| Natural Products as a Source for Novel Antibiotics | Q34529856 | ||
| Structure of microcin B-like compounds produced by Pseudomonas syringae and species specificity of their antibacterial action. | Q34818794 | ||
| Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE. | Q34912312 | ||
| Structure and biosynthesis of a macrocyclic peptide containing an unprecedented lysine-to-tryptophan crosslink | Q35645486 | ||
| The genomic landscape of ribosomal peptides containing thiazole and oxazole heterocycles | Q35805220 | ||
| Clostridium difficile drug pipeline: challenges in discovery and development of new agents | Q35846436 | ||
| A prevalent peptide-binding domain guides ribosomal natural product biosynthesis | Q35875602 | ||
| Thiostrepton inhibition of tRNA delivery to the ribosome | Q36148327 | ||
| Nonribosomal Peptide Synthesis-Principles and Prospects | Q36316177 | ||
| Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome. | Q36426304 | ||
| Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition. | Q36701111 | ||
| In Vitro Biosynthesis of the Core Scaffold of the Thiopeptide Thiomuracin | Q36761831 | ||
| Biosynthetic investigation of phomopsins reveals a widespread pathway for ribosomal natural products in Ascomycetes | Q36770494 | ||
| Insights into the mechanism of peptide cyclodehydrations achieved through the chemoenzymatic generation of amide derivatives | Q36973864 | ||
| A strain-variable bacteriocin in Bacillus anthracis and Bacillus cereus with repeated Cys-Xaa-Xaa motifs | Q37172458 | ||
| Streptolysin S-like virulence factors: the continuing sagA. | Q37592194 | ||
| Ribosome-targeting antibiotics and mechanisms of bacterial resistance. | Q38171225 | ||
| Klebsazolicin inhibits 70S ribosome by obstructing the peptide exit tunnel. | Q38605728 | ||
| Antibacterial drug discovery in the resistance era. | Q38704810 | ||
| YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function | Q38751212 | ||
| A new genome-mining tool redefines the lasso peptide biosynthetic landscape. | Q38752386 | ||
| The evolution of genome mining in microbes - a review. | Q38858040 | ||
| Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes | Q39109460 | ||
| Post-translational modifications involved in the biosynthesis of thiopeptide antibiotics | Q39208551 | ||
| Natural [4 + 2]-Cyclases | Q39261858 | ||
| Post-translational Claisen Condensation and Decarboxylation en Route to the Bicyclic Core of Pantocin A | Q39843455 | ||
| Opportunities for natural products in 21st century antibiotic discovery | Q40189627 | ||
| Unique post-translational oxime formation in the biosynthesis of the azolemycin complex of novel ribosomal peptides from Streptomyces sp. FXJ1.264 | Q41068761 | ||
| Dissecting Bottromycin Biosynthesis Using Comparative Untargeted Metabolomics | Q41920228 | ||
| A Trojan-Horse Peptide-Carboxymethyl-Cytidine Antibiotic from Bacillus amyloliquefaciens | Q42353708 | ||
| Escherichia coli peptidase A, B, or N can process translation inhibitor microcin C. | Q43112633 | ||
| The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition | Q43567998 | ||
| The translation initiation functions of IF2: targets for thiostrepton inhibition. | Q44708241 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P304 | page(s) | 226 | |
| P577 | publication date | 2020-03-31 | |
| P1433 | published in | Frontiers in Genetics | Q2499875 |
| P1476 | title | Translation-Targeting RiPPs and Where to Find Them | |
| P478 | volume | 11 |
Search more.